|Slideshows|August 26, 2020

Do Americans Trust Russia’s “Sputnik V” COVID-19 Vaccine?

Approximately 67% of US adults are wary about trusting Russia’s Sputnik V COVID-19 vaccine without proof, according to a new survey of >30 000 Americans.

Earlier this month, Russia became the first country to approve a vaccine against novel coronavirus disease 2019 (COVID-19), however, the August 11, 2020 announcement was met with global skepticism regarding the safety and effectiveness of the vaccine, called "Sputnik V."

With the number of confirmed COVID-19 cases in the US approaching 5.8 million and the death toll inching toward 200 000, how trusting are US adults of Russia's Sputnik V COVID-19 vaccine? To answer that question and more, data science company Piplsay surveyed 30 413 US adults aged ≥18 years between August 18-19, 2020. For more survey insights, click through the slideshow below.

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!

Latest CME

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person Event

Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

December 4, 2025

In-Person + Virtual Event

Breast Cancer Symposia in San Antonio

December 8-11, 2025

Virtual Event

Evolving Strategies and Emerging Agents in PTCL: Subtypes, Mutations, and Modern Therapies

December 19, 2025

In-Person + Virtual Event

GI Cancers Symposia

January 8, 2026

In-Person Event

23rd Annual Winter Lung Cancer Conference®

January 23-25, 2026

Do Americans Trust Russia’s “Sputnik V” COVID-19 Vaccine?

Newsletter

Related Content

Quiz: Recent Advances in Menopause and Midlife Women’s Health Research

Aggressive Risk Factor Management Reduced Recurrent AF by Nearly Half After Catheter Ablation

Genitourinary Syndrome of Menopause (GSM): Clinical FAQ for Primary Care

Screening for Breast Cancer in Patients With Dense Breast Tissue: A Q&A With Donna Plecha, MD

US Obesity Rates Decline in Tandem With Rise in Use of GLP-1 RA, New Gallup Index Shows

Latest CME

Southern Florida Psychiatry Conference

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Breast Cancer Symposia in San Antonio

Evolving Strategies and Emerging Agents in PTCL: Subtypes, Mutations, and Modern Therapies

GI Cancers Symposia

23rd Annual Winter Lung Cancer Conference®

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

10th Annual Live Medical Crossfire®: Hematologic Malignancies

27th Annual International Lung Cancer Congress®

Annual Hematology Meeting: Preceding the 67th ASH Annual Meeting and Exposition

Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

Community Collab: A Round Table Exploration of Effective Anesthesia with Vasoconstriction in Head and Neck Surgery

4th Annual International Congress on Pediatric Oncology

43rd Annual CFS®: Innovative Cancer Therapy for Tomorrow™

20th Annual New York Lung Cancers Symposium®

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

DSUI Urology on the Beach

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

2026 International Symposium of Gastrointestinal Oncology (ISGIO)

Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

23rd Annual School of Breast Oncology

26th Annual International Lung Cancer Congress

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Iowa

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | New York

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Minnesota

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | South Carolina

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Expert Perspectives on Technological Advances in Cataract Surgery

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Texas

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | West Virginia

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Virtual Tumor Board for the Onco-Nurse: Improving Outcomes in SCLC Treatment and AE Management

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Tennessee

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Washington

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Addressing Pivotal Updates in AML – Expert Perspectives on Individualizing Management for Special Populations

Expert Illustrations and Commentaries™: The Role of the Paracellular Pathway in the Management of Hyperphosphatemia in CKD

Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval

(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

Innovations in MDS Care: Navigating New Treatment Paradigms, Breakthrough Therapies, and Emerging Clinical Evidence

Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

Homing in on the Role of PSMA in Prostate Cancer – Harnessing the Power of Precision Medicine Through Imaging and Therapy to Individualize Treatment Plans

Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention

Community Oncology Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer – From Innovation to Practice | Louisiana

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Colorado

Community Oncology Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer – From Innovation to Practice | Montana and Wyoming

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Identifying and Treating CIDP in the Modern Era

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis